Thermo Fisher Scientific Lowers 2025 Adjusted EPS Guidance in Light of Tariffs, US Policy Changes
Premium
The new guidance reflects the impact from China-related tariffs as well as dampening US grant funding, partially offset by the firm's mitigation actions.
All children and adolescents with cancer in Ireland, including those who relapse following treatment, will be offered enrollment in the project.
Bird Flu Spread in US Dairy Herds After Single 2023 Spillover, Genomic Study Shows
Using genomics, phylogenetics, and epidemiological evidence, researchers characterized spillover, spread, and genetic changes in a highly pathogenic avian influenza virus.
The firm's core laboratory revenues declined 1 percent, while molecular laboratory sales were up 4 percent.
Guardant Health, Pfizer Partner to Use Liquid Biopsy to Aid Cancer Therapy Development
Pfizer intends to use Guardant's blood-based tests in global clinical trials, with specific plans to evaluate the clinical utility of its Reveal assay as clinical trial surrogate endpoint.
HudsonAlpha Launches Pilot Project to Study Genetics, Lifestyle of Alzheimer's Disease
The institute and its collaborators will assess participants' APOE status, pTau217 protein levels, and polygenic risk scores, and offer health and lifestyle coaching.
Interpace Diagnostics to Cease PancraGen Testing After Losing CMS Reimbursement
The fate of its pancreatic cancer test had been in limbo for years, but with a newly active LCD from Medicare contractor Novitas, the firm has had to close the book on the assay.
Basic Genomics Closes $1.2M Investment Round to Support RNA Analysis Tech
The company has not disclosed details of its BaseCode technology, which it claims to enable accurate, accessible, and cost-effective analysis of RNA molecules.